Geode Capital Management LLC Sells 156,573 Shares of Molina Healthcare, Inc $MOH

Geode Capital Management LLC cut its holdings in Molina Healthcare, Inc (NYSE:MOH) by 10.1% in the 4th quarter, HoldingsChannel.com reports. The fund owned 1,400,188 shares of the company’s stock after selling 156,573 shares during the period. Geode Capital Management LLC’s holdings in Molina Healthcare were worth $242,578,000 at the end of the most recent quarter.

Other hedge funds have also recently made changes to their positions in the company. Torren Management LLC bought a new position in shares of Molina Healthcare in the 4th quarter worth about $26,000. Miller Global Investments LLC bought a new position in shares of Molina Healthcare in the 4th quarter worth about $27,000. MUFG Securities EMEA plc bought a new position in shares of Molina Healthcare in the 2nd quarter worth about $48,000. Cromwell Holdings LLC raised its position in shares of Molina Healthcare by 211.9% in the 4th quarter. Cromwell Holdings LLC now owns 184 shares of the company’s stock worth $32,000 after acquiring an additional 125 shares in the last quarter. Finally, Rakuten Securities Inc. raised its position in shares of Molina Healthcare by 5,020.0% in the 4th quarter. Rakuten Securities Inc. now owns 256 shares of the company’s stock worth $44,000 after acquiring an additional 251 shares in the last quarter. 98.50% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Several research firms have recently weighed in on MOH. Cantor Fitzgerald lifted their price objective on Molina Healthcare from $144.00 to $209.00 and gave the stock a “neutral” rating in a research report on Monday, May 11th. Weiss Ratings reissued a “sell (d+)” rating on shares of Molina Healthcare in a research report on Tuesday, April 21st. Bank of America raised Molina Healthcare from an “underperform” rating to a “buy” rating and set a $250.00 price objective for the company in a research report on Wednesday, April 29th. Mizuho lowered their price objective on Molina Healthcare from $220.00 to $180.00 and set an “outperform” rating for the company in a research report on Thursday, March 12th. Finally, The Goldman Sachs Group lowered their price objective on Molina Healthcare from $167.00 to $124.00 and set a “neutral” rating for the company in a research report on Wednesday, February 11th. Three equities research analysts have rated the stock with a Buy rating, eleven have assigned a Hold rating and two have assigned a Sell rating to the company’s stock. According to MarketBeat.com, Molina Healthcare presently has a consensus rating of “Hold” and a consensus target price of $178.53.

Molina Healthcare Stock Performance

Shares of MOH opened at $179.73 on Wednesday. The company has a debt-to-equity ratio of 0.97, a current ratio of 1.63 and a quick ratio of 1.63. The stock has a 50-day moving average of $164.58 and a 200-day moving average of $161.21. The company has a market cap of $9.36 billion, a PE ratio of 53.17 and a beta of 0.80. Molina Healthcare, Inc has a one year low of $121.06 and a one year high of $311.52.

Molina Healthcare (NYSE:MOH) last issued its earnings results on Wednesday, April 22nd. The company reported $2.35 EPS for the quarter, beating the consensus estimate of $1.57 by $0.78. The company had revenue of $10.80 billion during the quarter, compared to the consensus estimate of $10.91 billion. Molina Healthcare had a return on equity of 8.76% and a net margin of 0.42%.The firm’s revenue for the quarter was down 3.1% compared to the same quarter last year. During the same period last year, the business posted $6.08 EPS. Molina Healthcare has set its FY 2026 guidance at 5.000- EPS. On average, equities research analysts predict that Molina Healthcare, Inc will post 5.23 EPS for the current fiscal year.

Insider Activity

In other news, insider Jeff D. Barlow sold 17,811 shares of the firm’s stock in a transaction dated Monday, May 11th. The stock was sold at an average price of $186.12, for a total value of $3,314,983.32. Following the completion of the sale, the insider directly owned 67,175 shares in the company, valued at $12,502,611. This trade represents a 20.96% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. Also, CAO Maurice Hebert sold 600 shares of the firm’s stock in a transaction dated Thursday, May 14th. The shares were sold at an average price of $191.55, for a total value of $114,930.00. Following the completion of the sale, the chief accounting officer owned 12,815 shares of the company’s stock, valued at approximately $2,454,713.25. This represents a 4.47% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Company insiders own 1.44% of the company’s stock.

Molina Healthcare Profile

Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.

The company traces its roots to the early 1980s, when Dr.